Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination
Metodi V. Stankov, Anne Cossmann, Agnes Bonifacius, Alexandra Dopfer-Jablonka, Gema Morillas Ramos, Nina Gödecke, Anna Zychlinsky Scharff, Christine Happle, Anna-Lena Boeck, Anh Thu Tran, Isabell Pink, Marius M. Hoeper, Rainer Blasczyk, Martin S. Winkler, Inga Nehlmeier, Amy Kempf, Heike Hofmann-Winkler, Markus Hoffmann, Britta Eiz-Vesper, Stefan Pöhlmann, View ORCID ProfileGeorg M.N. Behrens
doi: https://doi.org/10.1101/2021.04.16.21255412
Metodi V. Stankov
1Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
Anne Cossmann
1Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
Agnes Bonifacius
2Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
Alexandra Dopfer-Jablonka
1Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
3German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany
Gema Morillas Ramos
1Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
Nina Gödecke
2Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
Anna Zychlinsky Scharff
4Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany
Christine Happle
4Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany
5German Center for Lung Research, Biomedical Research in End Stage and Obstructive Lung Disease/BREATH, Hannover, Germany
Anna-Lena Boeck
6Department for Neurology, Hannover Medical School, Hannover, Germany
Anh Thu Tran
6Department for Neurology, Hannover Medical School, Hannover, Germany
Isabell Pink
7Department of Pneumology, Hannover Medical School, member of the German Centre for Lung Research (DZL), Hannover, Germany
Marius M. Hoeper
7Department of Pneumology, Hannover Medical School, member of the German Centre for Lung Research (DZL), Hannover, Germany
Rainer Blasczyk
2Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
Martin S. Winkler
8Department of Anaesthesiology and Intensive Care Unit, University of Göttingen Medical Center, Göttingen, Georg-August University of Göttingen, Göttingen, Germany
Inga Nehlmeier
9Infection Biology Unit, German Primate Center, Göttingen, Germany
Amy Kempf
9Infection Biology Unit, German Primate Center, Göttingen, Germany
Heike Hofmann-Winkler
9Infection Biology Unit, German Primate Center, Göttingen, Germany
Markus Hoffmann
9Infection Biology Unit, German Primate Center, Göttingen, Germany
10Faculty of Biology and Psychology, Georg-August-Universität Göttingen, Göttingen, Germany
Britta Eiz-Vesper
2Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
Stefan Pöhlmann
9Infection Biology Unit, German Primate Center, Göttingen, Germany
10Faculty of Biology and Psychology, Georg-August-Universität Göttingen, Göttingen, Germany
Georg M.N. Behrens
1Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
3German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany
11Centre for Individualized Infection Medicine (CiiM), Hannover, Germany
Article usage
Posted April 16, 2021.
Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination
Metodi V. Stankov, Anne Cossmann, Agnes Bonifacius, Alexandra Dopfer-Jablonka, Gema Morillas Ramos, Nina Gödecke, Anna Zychlinsky Scharff, Christine Happle, Anna-Lena Boeck, Anh Thu Tran, Isabell Pink, Marius M. Hoeper, Rainer Blasczyk, Martin S. Winkler, Inga Nehlmeier, Amy Kempf, Heike Hofmann-Winkler, Markus Hoffmann, Britta Eiz-Vesper, Stefan Pöhlmann, Georg M.N. Behrens
medRxiv 2021.04.16.21255412; doi: https://doi.org/10.1101/2021.04.16.21255412
Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination
Metodi V. Stankov, Anne Cossmann, Agnes Bonifacius, Alexandra Dopfer-Jablonka, Gema Morillas Ramos, Nina Gödecke, Anna Zychlinsky Scharff, Christine Happle, Anna-Lena Boeck, Anh Thu Tran, Isabell Pink, Marius M. Hoeper, Rainer Blasczyk, Martin S. Winkler, Inga Nehlmeier, Amy Kempf, Heike Hofmann-Winkler, Markus Hoffmann, Britta Eiz-Vesper, Stefan Pöhlmann, Georg M.N. Behrens
medRxiv 2021.04.16.21255412; doi: https://doi.org/10.1101/2021.04.16.21255412
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2957)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4603)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4380)
- Nursing (237)
- Nutrition (640)
- Oncology (2281)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1198)
- Primary Care Research (499)
- Public and Global Health (6967)
- Radiology and Imaging (1536)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)